CMMB Chemomab Therapeutics Ltd.

NASDAQ
$2.16

Chemomab Therapeutics Ltd. (CMMB) Seasonality

What this stock has historically done over the three months following this point in the calendar year, measured against every other three-month stretch on record.

The three months from August 22

From August, on average
+20.90%
25 matching years
Any three months
-2.90%
1,301 starting points
Difference
+23.8 pts
better than usual

Both lines start at zero on day 0, so the vertical gap reads directly as percentage points better or worse than a random three months. A seasonal line sitting on top of the baseline is a real answer: it says the calendar tells you nothing here. Price history from March 2021 to August 2026.

Between earnings releases

The same study run on the earnings cycle rather than the calendar: the average move from one report to the next, broken out by fiscal quarter, with the announcement gap and the run-up separated out.

Sign in or subscribe to see it